4//SEC Filing
Donadio Jamie A 4
Accession 0001214659-19-001354
CIK 0001576263other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:00 PM ET
Size
9.2 KB
Accession
0001214659-19-001354
Insider Transaction Report
Form 4
Donadio Jamie A
VP of Finance
Transactions
- Sale
Common Stock
2019-02-15$75.00/sh−7,500$562,502→ 221 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-15−7,500→ 30,000 totalExercise: $5.40Exp: 2027-01-25→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2019-02-15$5.40/sh+7,500$40,500→ 7,721 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June14, 2018.
- [F2]This transaction was executed in multiple trades at prices ranging from $75.00 to $75.015. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001579771
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:00 PM ET
- Size
- 9.2 KB